| Date | Time | Source | Announcement |
|---|---|---|---|
| 11 May 2005 | 07:00 AM | Result of AGM | |
| 06 May 2005 | 08:35 AM | Launch of Tabella eXpress | |
| 29 Apr 2005 | 02:50 PM | Holding(s) in Company | |
| 29 Apr 2005 | 08:44 AM | Holding(s) in Company | |
| 29 Apr 2005 | 08:43 AM | Holding(s) in Company | |
| 27 Apr 2005 | 07:00 AM | Additional Listing | |
| 21 Apr 2005 | 09:48 AM | Acquisition | |
| 21 Apr 2005 | 09:07 AM | Holding(s) in Company | |
| 21 Apr 2005 | 09:06 AM | Holding(s) in Company | |
| 14 Apr 2005 | 07:00 AM | Additional Listing | |
| 11 Apr 2005 | 04:14 PM | Holding(s) in Company | |
| 05 Apr 2005 | 12:25 PM | Additional Listing | |
| 04 Apr 2005 | 07:02 AM | Final Results | |
| 04 Apr 2005 | 07:00 AM | Acquisition | |
| 31 Mar 2005 | 04:40 PM | Additional Listing | |
| 31 Mar 2005 | 04:34 PM | Holding(s) in Company | |
| 31 Mar 2005 | 09:48 AM | Notice of Results | |
| 30 Mar 2005 | 10:53 AM | Holding(s) in Company | |
| 17 Mar 2005 | 07:00 AM | Additional Listing | |
| 16 Mar 2005 | 05:56 PM | Holding(s) in Company | |
| 16 Mar 2005 | 04:34 PM | Holding(s) in Company | |
| 14 Mar 2005 | 10:52 AM | Additional Listing | |
| 11 Mar 2005 | 04:35 PM | Holding(s) in Company | |
| 28 Feb 2005 | 11:47 AM | Holding(s) in Company | |
| 25 Feb 2005 | 07:00 AM | Holding(s) in Company | |
| 24 Feb 2005 | 12:05 PM | Holding(s) in Company | |
| 24 Feb 2005 | 07:00 AM | Additional Listing | |
| 18 Feb 2005 | 04:49 PM | Holding(s) in Company | |
| 17 Feb 2005 | 12:43 PM | Holding(s) in Company | |
| 15 Feb 2005 | 09:46 AM | Holding(s) in Company | |
| 08 Feb 2005 | 07:27 AM | New mobile email service | |
| 21 Jan 2005 | 02:45 PM | Contract Win | |
| 20 Dec 2004 | 04:51 PM | Holding(s) in Company | |
| 20 Dec 2004 | 04:05 PM | Holding(s) in Company | |
| 14 Dec 2004 | 08:00 AM | First Day of Dealings on AIM |
Syncona Limited is a Guernsey-based investment company focusing on long-term capital appreciation through investments in life science businesses and single or multi-asset projects. The company aims to build a diversified portfolio of global healthcare companies, with a focus on developing treatments for patients by partnering with academic founders and management teams. Syncona's investment objective is to achieve superior long-term capital appreciation.
Syncona share price launched at 104p in 2012.